Indocyanine Green
FDA-approved product (injectable, injection), marketed as Ic-Green, Indocyanine Green, Spy Agent Green Kit and 1 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 2 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Indocyanine Green. Its therapeutic class is shown instead.
- WHO therapeutic group
- Other diagnostic agents
- FDA pharmacologic class
- Diagnostic Dye FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA and M. tuberculosis. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA41.4% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli35.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae26.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis58.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Indocyanine Green with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Pipecuronium BromideExisting use: Other quaternary ammonium compounds42.9% AI-predicted activityagainst K. pneumoniae5 registered studies
- Fosaprepitant DimeglumineExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more42.9% AI-predicted activityagainst K. pneumoniae21 registered studies
- CabergolineExisting use: Hypothalamic neoplasm, Parkinson disease42.8% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Fondaparinux SodiumExisting use: Deep vein thrombosis, Intermediate coronary syndrome, Myocardial infarction and 3 more42.7% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Zavegepant HydrochlorideExisting use: Migraine disorder42.6% AI-predicted activityagainst K. pneumoniaeNo documented evidence found
- ApalutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 3 more42.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Vecuronium BromideExisting use: Other quaternary ammonium compounds42.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Lenacapavir SodiumExisting use: HIV infection, HIV-1 infection, Viral disease42.0% AI-predicted activityagainst K. pneumoniaeNo documented evidence found
- Lumateperone TosylateExisting use: Psychosis, Schizophrenia41.9% AI-predicted activityagainst K. pneumoniae6 registered studies
- RepotrectinibExisting use: Cancer, Neoplasm41.8% AI-predicted activityagainst K. pneumoniae17 registered studies
- MoxidectinExisting use: Helminthiasis, Onchocerciasis41.7% AI-predicted activityagainst K. pneumoniae25 registered studies
- PralsetinibExisting use: Cancer, Medullary thyroid gland carcinoma, Neoplasm and 1 more41.5% AI-predicted activityagainst K. pneumoniae19 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
ICG for Visualization of the Ureters in DIE
NCT05206279 · start 2023-06-26
Registered record
- Registry ID
- NCT05206279
- Conditions
- Visualization of Ureters in Gynecological Surgery; Deep Infiltrative Endometriosis; ICG (Indocyanine Green); Near Infrared Imaging; Laparoscopy
- Interventions
- Ureteral injection of Indocyanine Green Powder (diluted)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-06-26
- Completion
- 2024-09-01
- Enrolment
- 51
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVisualization of Ureters in Gynecological Surgery; Deep Infiltrative Endometriosis; ICG (Indocyanine Green); Near Infrared Imaging +1 moreInterventionUreteral injection of Indocyanine Green Powder (diluted)PhaseNot applicableRegistry statusCompletedApplications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
NCT06033794 · start 2023-05-01
Registered record
- Registry ID
- NCT06033794
- Conditions
- Fluorescence; Indocyanine Green; Rectal Cancer Surgery
- Interventions
- Fluorescence laparoscopic system
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2023-05-01
- Completion
- 2024-05-01
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFluorescence; Indocyanine Green; Rectal Cancer SurgeryInterventionFluorescence laparoscopic systemPhaseNot applicableRegistry statusUnknownFluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes
NCT05593523 · start 2023-03-09
Registered record
- Registry ID
- NCT05593523
- Conditions
- Burn Wound
- Interventions
- Indocyanine green (ICG); Clinical Fluorescence Imaging Device
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2023-03-09
- Completion
- 2028-03
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBurn WoundInterventionIndocyanine green (ICG); Clinical Fluorescence Imaging DevicePhaseNot recordedRegistry statusActive not recruitingCost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.
NCT05699291 · start 2023-02-23
Registered record
- Registry ID
- NCT05699291
- Conditions
- Sentinel Lymph Node
- Interventions
- Sentinel node detection technique
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2023-02-23
- Completion
- 2024-05-17
- Enrolment
- 163
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSentinel Lymph NodeInterventionSentinel node detection techniquePhaseNot recordedRegistry statusCompletedPerformance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery
NCT05588414 · start 2022-12-05
Registered record
- Registry ID
- NCT05588414
- Conditions
- Breast Cancer
- Interventions
- Standardization of the sentinel node detection procedure
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-12-05
- Completion
- 2024-06-27
- Enrolment
- 392
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBreast CancerInterventionStandardization of the sentinel node detection procedurePhaseNot applicableRegistry statusCompletedA Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"
NCT04930692 · start 2022-10-01
Registered record
- Registry ID
- NCT04930692
- Conditions
- Breast Neoplasms; Sentinel Lymph Node
- Interventions
- Contrast-enhanced CT lymphography with the periareolar injection of iopamidol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2022-10-01
- Completion
- 2023-08-01
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBreast Neoplasms; Sentinel Lymph NodeInterventionContrast-enhanced CT lymphography with the periareolar injection of iopamidolPhaseNot applicableRegistry statusUnknownPrognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis
NCT05800561 · start 2022-01-01
Registered record
- Registry ID
- NCT05800561
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Hepatic venous-portal gradient (HVPG) measurement
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2022-01-01
- Completion
- 2024-01-31
- Enrolment
- 208
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHepatocellular CarcinomaInterventionHepatic venous-portal gradient (HVPG) measurementPhaseNot recordedRegistry statusUnknownIndocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer
NCT04973475 · start 2021-07
Registered record
- Registry ID
- NCT04973475
- Conditions
- Early Gastric Cancer; Indocyanine Green; Lymph Node Dissection
- Interventions
- Indocyanine Green
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Unknown
- Start
- 2021-07
- Completion
- 2026-07
- Enrolment
- 180
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEarly Gastric Cancer; Indocyanine Green; Lymph Node DissectionInterventionIndocyanine GreenPhasePhase 2Registry statusUnknownA Study of Intra-operative Imaging in Women With Ovarian Cancer
NCT04878094 · start 2021-05-03
Registered record
- Registry ID
- NCT04878094
- Conditions
- Ovarian Cancer; Ovarian Carcinoma
- Interventions
- Intravenous Indocyanine Green/ICG injection; PINPOINT endoscopic fluorescence imaging system; Endoscopy
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Active not recruiting
- Start
- 2021-05-03
- Completion
- 2027-05-03
- Enrolment
- 155
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOvarian Cancer; Ovarian CarcinomaInterventionIntravenous Indocyanine Green/ICG injection; PINPOINT endoscopic fluorescence imaging system; EndoscopyPhasePhase 3Registry statusActive not recruitingSentinel Node Biopsy in Endometrial Cancer
NCT04073706 · start 2021-01-18
Registered record
- Registry ID
- NCT04073706
- Conditions
- Endometrial Cancer Stage I; Sentinel Lymph Node; Surgery
- Interventions
- TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted; TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Recruiting
- Start
- 2021-01-18
- Completion
- 2031-02
- Enrolment
- 760
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEndometrial Cancer Stage I; Sentinel Lymph Node; SurgeryInterventionTH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted; TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omittedPhasePhase 3Registry statusRecruitingFuture of Colorectal Cancer Surgery
NCT04220242 · start 2019-12-30
Registered record
- Registry ID
- NCT04220242
- Conditions
- Colorectal Cancer; Surgery
- Interventions
- Video recordings with analysis thereafter applied; Examination of microsections of tissue excised for the purposes of cancer resection; Cancer organoid development and testing
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2019-12-30
- Completion
- 2023-03-01
- Enrolment
- 250
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionColorectal Cancer; SurgeryInterventionVideo recordings with analysis thereafter applied; Examination of microsections of tissue excised for the purposes of cancer resection; Cancer organoid development and testingPhaseNot recordedRegistry statusUnknownHyperbaric Oxygenation in Diabetic Ulcer
NCT02042339 · start 2019-12
Registered record
- Registry ID
- NCT02042339
- Conditions
- Diabetes Mellitus
- Interventions
- Hyperbaric oxygen
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2019-12
- Completion
- 2022-12
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiabetes MellitusInterventionHyperbaric oxygenPhasePhase 3Registry statusUnknownUse of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
NCT04882618 · start 2019-11-08
Registered record
- Registry ID
- NCT04882618
- Conditions
- Prostate Cancer; Lymph Node Metastases
- Interventions
- Indocyanine green
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2019-11-08
- Completion
- 2021-11-08
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionProstate Cancer; Lymph Node MetastasesInterventionIndocyanine greenPhasePhase 4Registry statusUnknownLong-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
NCT03929731 · start 2019-07-05
Registered record
- Registry ID
- NCT03929731
- Conditions
- Polypoidal Choroidal Vasculopathy
- Interventions
- Indocyanine Green Angiography
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2019-07-05
- Completion
- 2024-05-09
- Enrolment
- 72
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPolypoidal Choroidal VasculopathyInterventionIndocyanine Green AngiographyPhaseNot recordedRegistry statusCompletedEffect of Exercise on Indocyanine Green (ICG) Lymphography Imaging
NCT03584633 · start 2019-04-15
Registered record
- Registry ID
- NCT03584633
- Conditions
- Lymphedema
- Interventions
- Indocyanine Green
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2019-04-15
- Completion
- 2019-12-31
- Enrolment
- 9
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLymphedemaInterventionIndocyanine GreenPhasePhase 4Registry statusCompleted